The Europe sickle cell disease (SCD) treatment market reached US $883.3 million in 2024 and is projected to soar to US $2.49 billion by 2033, growing at a robust CAGR of 15.7% from 2025 to 2033 https://www.datamintelligence.com/research-report/europe-sickle-cell-disease-treatment-market